Status:
COMPLETED
ENTRUST, a 5 Year Surveillance of Children Aged 2 to <6 Years With Transfusional Iron Overload Treated With Deferasirox
Lead Sponsor:
Novartis Pharmaceuticals
Conditions:
Anemia
Eligibility:
All Genders
2-5 years
Brief Summary
This registry will evaluate long-term safety and efficacy of deferasirox in children with transfusional iron overload.
Eligibility Criteria
Inclusion
- History of transfusion-dependent anemia.
- History of iron overload
Exclusion
- Patients with non-transfusional hemosiderosis.
- Other protocol-defined inclusion/exclusion criteria may apply.
Key Trial Info
Start Date :
May 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2015
Estimated Enrollment :
108 Patients enrolled
Trial Details
Trial ID
NCT00466063
Start Date
May 1 2007
End Date
July 1 2015
Last Update
December 29 2015
Active Locations (23)
Enter a location and click search to find clinical trials sorted by distance.
1
University of South Alabama Medical Center
Mobile, Alabama, United States, 36604
2
Children's Hospital Los Angeles
Los Angeles, California, United States, 90027
3
Children's Hospital Oakland
Oakland, California, United States, 94609
4
Children's Hospital of Orange County
Orange, California, United States, 92868-3874